BioArctic AB (publ) (BIOA-B) — Cash Flow Reinvestment Rate

Latest as of December 2025: 1.00x

BioArctic AB (publ) (BIOA-B) has a Cash Flow Reinvestment Rate of 1.00x as of December 2025, reinvesting Skr313.33 Million (capex Skr313.33 Million ) from operating cash flow of Skr313.33 Million. See BioArctic AB (publ) (BIOA-B) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.00x
(Capex + Investments) / Operating CF

Total Reinvested

Skr313.33 Million
Capex + Investments

Operating Cash Flow

Skr313.33 Million
SEK

Capital Expenditures

Skr313.33 Million
SEK

BioArctic AB (publ) Cash Flow Reinvestment Rate (2016–2025)

Historical reinvestment intensity for BioArctic AB (publ) across 4 annual periods. For the full cash flow conversion analysis, see BioArctic AB (publ) cash conversion from operations.

Annual Cash Flow Reinvestment Rate for BioArctic AB (publ) (2016–2025)

Year-by-year capital reinvestment analysis for BioArctic AB (publ). See financial agility of BioArctic AB (publ) to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2025 0.63x Skr894.65 Million Skr1.43 Billion Skr10.24 Million ▼ -38.3%
2023 1.01x Skr314.00 Million Skr309.69 Million Skr7.44 Million ▲ +10035.0%
2019 0.01x Skr3.27 Million Skr327.17 Million Skr3.26 Million ▲ +13.7%
2016 0.01x Skr5.94 Million Skr675.13 Million Skr2.97 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow